glp-1 obesity drug news today Alarming rise in weight loss overdoses Does stopping GLP-1s make you
Description
Insurers weigh the short-term cost of GLP-1 therapies (up to ~$17K annually) against the long-term savings from reduced obesity-related complications
Bibcode:2017JBiCh.292.7131K
Lemen, Y
doi: 10.1007/s12020-014-0361-4
This may suggest that the observation of a benefit of the GLP-1 RAs on heart failure hospitalisation as found in the meta-analysis by Sattar and colleagues is driven by data from AMPLITUDE-O and Harmony Outcomes
When to Choose Tirzepatide Over Semaglutide: Maximum Weight Loss Needed: If you need to lose 50+ pounds, tirzepatides superior results (5-7% more weight loss) justify the extra cost
